These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2856270)

  • 21. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1403-6. PubMed ID: 3824502
    [No Abstract]   [Full Text] [Related]  

  • 22. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine.
    Erturk E; Bretan P; Pestana J; Steinmuller D; Stowe NT; Novick AC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):932-3. PubMed ID: 2705261
    [No Abstract]   [Full Text] [Related]  

  • 25. [The renin-angiotensin system and renal adaptation to sodium restriction].
    Mimran A; Jover B; Dupont M; Casellas D
    Nephrologie; 1985; 6(3):127-31. PubMed ID: 3001555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
    Silva FM; Miorin LA; Sens YA
    Ren Fail; 2008; 30(4):439-42. PubMed ID: 18569919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.
    Ijzermans JN; Singh SK; de Bruin RW; Bouwman E; Weimar W; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1385-6. PubMed ID: 3274337
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
    Makowka L; Lopatin W; Gilas T; Falk J; Phillips MJ; Falk R
    Clin Nephrol; 1986; 25 Suppl 1():S89-94. PubMed ID: 3708941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
    Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
    Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A nephrotoxicity in streptozotocin-diabetic rats.
    Whiting PH; Thomson KJ; Saunders NJ; Simpson JG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):946-7. PubMed ID: 2705263
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats.
    Iacona A; Rossetti A; Filingeri V; Orsini D; Cesarini A; Cervelli V; Adorno D; Casciani CU
    Drugs Exp Clin Res; 1991; 17(10-11):501-6. PubMed ID: 1841039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role for reactive oxygen species in cyclosporin A induced nephrotoxicity in rats.
    Kumano K; Yoshida K; Iwamura M; Endo T; Sakai T; Nakamura K; Kuwao T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):941-2. PubMed ID: 2705262
    [No Abstract]   [Full Text] [Related]  

  • 37. Nephrotoxicity of cyclosporine and its prevention by concomitant administration of prednisolone: biochemical and morphological analysis.
    Suzuki S; Oka T; Ohkuma S; Kuriyama K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1398-402. PubMed ID: 2435031
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of captopril and theophylline treatment on cyclosporine-induced nephrotoxicity in rats.
    Gerkens JF; Smith AJ
    Transplantation; 1985 Aug; 40(2):213-4. PubMed ID: 2992131
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electron microscopic observation of the nephrotoxicity in rats receiving cyclosporine].
    Kimura S; Hasegawa S; Nakazono M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):563-71. PubMed ID: 3669468
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of age and dosage route on experimental cyclosporine nephrotoxicity.
    Bennett WM; Lindsley J; Buss WC
    Transplantation; 1991 Mar; 51(3):730-1. PubMed ID: 2006533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.